AmerisourceBergen is one of the world's largest pharmaceutical services companies serving global markets with a focus on the pharmaceutical supply chain. Servicing both pharmaceutical manufacturers and healthcare providers, The Company provides drug distribution and related services designed to reduce costs and improve patient outcomes.
Type
Public
HQ
Chesterbrook, US
Founded
2001
Size (employees)
20,000 (est)+12%
AmerisourceBergen was founded in 2001 and is headquartered in Chesterbrook, US
Report incorrect company information

Key People/Management at AmerisourceBergen

Steven Collis

Steven Collis

Chairman, President and Chief Executive Officer
Kathy Gaddes

Kathy Gaddes

Executive Vice President and Chief Human Resources Officer
Albert Morales

Albert Morales

Chief Transformation Officer
Tim Guttman

Tim Guttman

Executive Vice President and Chief Financial Officer
John Chou

John Chou

Executive Vice President and Chief Legal & Business Officer
Gina Clark

Gina Clark

Executive Vice President and Chief Communications & Administration Officer
Show more

AmerisourceBergen Office Locations

AmerisourceBergen has an office in Chesterbrook
Chesterbrook, US (HQ)
1300 Morris Dr
Show all (1)
Report incorrect company information

AmerisourceBergen Financials and Metrics

AmerisourceBergen Financials

AmerisourceBergen's revenue was reported to be $153.14 t in FY, 2017
USD

Revenue (FY, 2017)

153.1 t

Gross profit (FY, 2017)

4.5 t

Gross profit margin (FY, 2017), %

3%

Net income (FY, 2017)

364.5 b

EBIT (FY, 2017)

1.1 t

Market capitalization (23-Apr-2018)

20 b

Cash (30-Sep-2017)

2.4 b

EV

21 b
AmerisourceBergen's current market capitalization is $20 b.
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017

Revenue

119.6 b136 b146.8 b153.1 t

Revenue growth, %

36%14%8%

Cost of goods sold

116.6 b132.4 b142.6 b148.6 t

Gross profit

3 b3.5 b4.3 b4.5 t
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Revenue

29.2 b28.5 b30.3 b33.6 b32.7 b34.2 b36.7 b35.7 b36.9 b38.2 b37.1 b38.7 b

Cost of goods sold

28.5 b27.7 b29.7 b32.8 b31.8 b33.3 b35.7 b34.6 b35.8 b37.1 b35.9 b37.6 b

Gross profit

688.2 m729.6 m692 m752.3 m912 m891.5 m964.9 m1.1 b1.1 b1 b1.3 b1.1 b

Gross profit Margin, %

2%3%2%2%3%3%3%3%3%3%3%3%
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017

Cash

1.8 b2.2 b2.7 b2.4 b

Accounts Receivable

(1.3 b)

Current Assets

16.8 b20.3 b22.9 b24.3 b

PP&E

899.6 m979.3 m1.5 b1.8 b
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Cash

347.5 m696.7 m1.3 b2.3 b2.3 b2.6 b978.1 m2.5 b1.9 b1.8 b2.4 b1.3 b

Current Assets

15.2 b15.8 b15.9 b20.1 b19.6 b19.9 b20.4 b22.1 b21.5 b23.1 b23.5 b23.7 b

PP&E

824.1 m850.8 m882.2 m907 m955.6 m958.7 m1.1 b1.1 b1.2 b1.6 b1.7 b1.7 b

Goodwill

6 b6 b6 b
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017

Net Income

276.5 m(134.9 m)145.7 b364.5 m

Depreciation and Amortization

237.1 b

Accounts Payable

2.3 b5.1 b3 b1.5 b

Cash From Operating Activities

1.5 b3.9 b3.2 b1.5 b
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Net Income

41.4 m221.5 m208.7 m(199.9 m)(713.3 m)(499.2 m)330.4 m934.5 m1.3 b247.2 m658.7 m709.1 m

Accounts Payable

247.8 m351 m877 m

Cash From Operating Activities

(1 b)112.7 m632.5 m897 m1.6 b2.8 b750.8 m1.6 b1.8 b(430.4 m)368.4 m123.7 m

Cash From Investing Activities

(68.2 m)(128.1 m)(319.2 m)(77.2 m)(2.7 b)(2.7 b)(2.8 b)(2.9 b)(3 b)(156.9 m)(269.5 m)(406.6 m)
USDY, 2017

EV/CFO

14 x

EV/FCF

20.3 x

Revenue/Employee

8.4 b

Debt/Equity

1.7 x

Debt/Assets

0.1 x

Financial Leverage

17.1 x
Show all financial metrics

AmerisourceBergen Operating Metrics

FY, 2016

Countries

50

Distribution Centers

26
Show all operating metrics

AmerisourceBergen Acquisitions / Subsidiaries

Acquired CompanyDateDeal Size
MWI Veterinary Supply January 12, 2015$2.50 b
TheraCom December 31, 2011$250 m
IntrinsiQ September 06, 2011$35 m
Report incorrect company information

AmerisourceBergen News and Updates

Biopharmaceutical Logistics Market: Growing Demand for Targeted Therapies to Create Exciting Opportunities

Biopharmaceutical Logistics Market categorizes the global market by Type (Cold Chain Logistics and Non-cold Chain Logistics), Mode of Transportation (Air, Sea, Road, and Rail Shipping), Service & Geography Posted via Industry Today. Follow us on Twitter @IndustryToday

Judge charts course to trial for opioid litigation as settlement talks hit barriers

Drugmakers haven't been able to reach a settlement with the hundreds of cities and counties suing them over the opioid epidemic, so a judge is planning early court trials that could point the way to a deal.

Lawsuit In Small Town Louisiana Could Pose Major Threat To Opioid Manufacturers

The suit could potentially overshadow a far bigger federal case.

McKesson, Cardinal and AmerisourceBergen scrutinized over opioid arm-twisting

Investors are demanding change at the top of the Big Three drug distributors after a bombshell investigation exposed a lack of opioid controls—and a successful push on Capitol Hill to hobble the DEA.
Report incorrect company information